Karyn Kaplan
Impact in
- Epidemiology top 5%
- HIV, Drug Use, Sexual Risk
- Substance Abuse Treatment and Outcomes
- Hepatitis B Virus Studies
- Infectious Diseases top 10%
- HIV/AIDS Research and Interventions
Papers in
- Epidemiology 34
- HIV, Drug Use, Sexual Risk 33
- Hepatitis B Virus Studies 2
-
- HIV/AIDS Research and Interventions 8
- Co-authors
- Thomas Kerr (32 shared papers)Paisan Suwannawong (33 shared papers)Kanna Hayashi (31 shared papers)Evan Wood (28 shared papers)Lianping Ti (21 shared papers)Nadia Fairbairn (11 shared papers)Calvin Lai (3 shared papers)Ruth Zhang (3 shared papers)
- Journals
- International Journal of Drug Policy (5 papers)Harm Reduction Journal (5 papers)BMC Public Health (3 papers)Drug and Alcohol Review (3 papers)Substance Abuse Treatment Prevention and Policy (3 papers)
- Partner nations
- CanadaThailandUnited States
In The Last Decade
Karyn Kaplan
38 papers receiving 552 citations
Peers
Comparison fields: 5 of 47
- Epidemiology 414
- Infectious Diseases 109
- Virology 24
- Hepatology 36
- Toxicology 15
Countries citing papers authored by Karyn Kaplan
This map shows the geographic impact of Karyn Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karyn Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karyn Kaplan more than expected).
Fields of papers citing papers by Karyn Kaplan
This network shows the impact of papers produced by Karyn Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karyn Kaplan. The network helps show where Karyn Kaplan may publish in the future.
Co-authors
The 25 scholars most cited alongside Karyn Kaplan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 38 | |
| 2 | 2012 | 35 | |
| 3 | 2013 | 34 | |
| 4 | 2012 | 28 | |
| 5 | 2010 | 28 | |
| 6 | 2009 | 26 | |
| 7 | 2011 | 24 | |
| 8 | 2012 | 24 | |
| 9 | 2015 | 24 | |
| 10 | 2010 | 22 | |
| 11 | 2013 | 22 | |
| 12 | 2017 | 21 | |
| 13 | 2011 | 21 | |
| 14 | 2010 | 18 | |
| 15 | 2009 | 17 | |
| 16 | 2012 | 17 | |
| 17 | 2017 | 17 | |
| 18 | 2012 | 17 | |
| 19 | 2014 | 16 | |
| 20 | 2010 | 16 |
About Karyn Kaplan
Karyn Kaplan is a scholar working on Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health, Virology and General Health Professions, having authored 38 papers that have together received 584 indexed citations. Recurring topics across this work include HIV, Drug Use, Sexual Risk (33 papers), HIV/AIDS Research and Interventions (8 papers), Opioid Use Disorder Treatment (5 papers), HIV Research and Treatment (3 papers), Health Policy Implementation Science (2 papers), Sex work and related issues (2 papers), Hepatitis B Virus Studies (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Epidemiology (414 citations), Infectious Diseases (109 citations), Virology (24 citations), Hepatology (36 citations) and Toxicology (15 citations). Karyn Kaplan has collaborated with scholars based in Canada, Thailand and United States. Frequent co-authors include Thomas Kerr, Paisan Suwannawong, Kanna Hayashi, Evan Wood, Lianping Ti, Nadia Fairbairn, Calvin Lai, Ruth Zhang, M‐J Milloy and Julio Montaner. Their work appears in journals such as International Journal of Drug Policy, Harm Reduction Journal, BMC Public Health, Drug and Alcohol Review and Substance Abuse Treatment Prevention and Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.